<?xml version="1.0" encoding="UTF-8"?>
<p id="Par58">Most patients (70.1% of the study population) had at least one comorbidity (other than psychiatric). Group A individuals were more likely to have at least one additional comorbidity before starting DAA-treatment (78.2% vs. 51.2%, 
 <italic>p</italic> = 0.002). Arterial hypertension was the most common reported comorbidity (42.4%), mainly diagnosed in patients belonging to group A (52.5% vs. 18.6%, 
 <italic>p</italic> &lt; 0.001).
</p>
